Plain-language explanation, inspection context and common violation patterns.
E2D(R1) provides definitions and standards for managing and reporting safety information after a medicine is approved, including adverse event and adverse reaction definitions, sources of case information such as spontaneous reports, literature and solicited reports, the minimum information needed for a valid case, and expectations for expedited reporting and follow-up.
Paraphrased for plain-language clarity. Always verify against the current published regulation text.
Adverse event information received by a non-safety department that was not passed on in time.
GMPify's Regulation Explainer tool gives subscribers an AI-powered analysis of any 21 CFR, EU GMP, USP or ICH reference, with live inspection context.
Try the Regulation Explainer →